Brain Fog News and Research

RSS

Lithium aspartate fails to improve long COVID symptoms, but higher doses may hold promise

Lithium aspartate at 10-15 mg/d is ineffective for treating cognitive dysfunction and fatigue in long COVID, but higher doses may offer potential benefits based on a small follow-up study.

3 Oct 2024

Low-dose lithium fails in long COVID trial, but higher doses show potential

A small University at Buffalo clinical trial has found that at low doses, lithium aspartate is ineffective in treating the fatigue and brain fog that is often a persistent feature of long COVID; however, a supplemental dose-finding study found some evidence that higher doses may be effective.

3 Oct 2024

How viral persistence and immune dysfunction drive long COVID

Study explores the biological drivers and mechanisms of long COVID, shedding light on its epidemiology and potential therapeutic interventions. It emphasizes the role of viral persistence, immune dysfunction, and coagulation in the development of this condition.

29 Sep 2024

Nursing aides plagued by PTSD after ‘nightmare’ covid conditions, with little help

One evening in May, nursing assistant Debra Ragoonanan's vision blurred during her shift at a state-run Massachusetts veterans home.

26 Sep 2024

Human challenge study reveals lasting cognitive decline after mild COVID-19

Researchers from the UK conducted the first human challenge study of SARS-CoV-2, revealing long-lasting cognitive deficits in unvaccinated participants infected with the virus, especially in memory and executive function.

23 Sep 2024

Study reveals high incidence of orthostatic intolerance in children with long COVID

A new study from Kennedy Krieger Institute shows that the majority of children diagnosed with long COVID are likely to experience orthostatic intolerance (OI), a condition that causes the body to struggle with regulating blood pressure and heart rate when standing up.

16 Sep 2024

New initiative aims to support menopausal workers and reduce employer costs

Menopause is a natural life transition occurring when many women are at the "top of their game." Unsupported menopause symptoms drive up employer healthcare costs and cause roughly $1.8 billion in missed workdays.

13 Sep 2024

Long COVID significantly affects children for up to 36 months, vaccines offer crucial protection

Study reveals the significant and lasting impact of long COVID on children, emphasizing the protective role of vaccines and the increased risk of autoimmune disorders.

8 Sep 2024

New approach to treat post-COVID symptoms

In a world still grappling with the aftermath of the COVID-19 pandemic, a team of international researchers has proposed a novel approach to treating the persistent symptoms that plague many survivors of viral infections. The study, published on 30 August 2024 in Brain Medicine (ISSN: 2997-2639, Genomic Press, New York), outlines a multimodal treatment strategy that could offer hope to millions suffering from post-acute infectious syndromes (PAIS), including the condition commonly known as Long COVID.

4 Sep 2024

Long COVID symptom severity varies widely by age, gender, and socioeconomic status

Study analyzes self-reported long COVID symptoms through a healthcare app, revealing that symptom severity significantly varies by demographic factors such as age, gender, race, education, and socioeconomic status.

2 Sep 2024

Study reveals the role of blood clotting in COVID-19

In a study that reshapes what we know about COVID-19 and its most perplexing symptoms, scientists have discovered that the blood coagulation protein fibrin causes the unusual clotting and inflammation that have become hallmarks of the disease, while also suppressing the body's ability to clear the virus.

29 Aug 2024

Mutation in SARS-CoV-2 spike protein enhances brain infection

Scientists have discovered a mutation in SARS-CoV-2, the virus that causes COVID-19, that plays a key role in its ability to infect the central nervous system.

23 Aug 2024

Study reveals long COVID's wide impact on children's health

The kids were correct all along. In the most comprehensive national study since the onset of the COVID-19 pandemic, a team of researchers that includes a Rutgers-organized consortium of pediatric sites has concluded that long COVID symptoms in children are tangible, pervasive, wide ranging and clinically distinct within specific age groups.

22 Aug 2024

Long COVID symptoms may stem from low cortisol and altered brain immune response

Proteins left behind by COVID-19 long after initial infection can cause cortisol levels in the brain to plummet, inflame the nervous system and prime its immune cells to hyper-react when another stressor arises, according to new animal research by University of Colorado Boulder scientists.

19 Aug 2024

Study finds no clinically useful biomarkers for long COVID in routine lab tests

Whether tests in current use were adequate to identify post-acute sequelae of SARS-CoV-2 (PASC).

14 Aug 2024

Routine lab tests fail to identify reliable biomarkers for long COVID, study finds

Study found no reliable clinical biomarkers for diagnosing PASC (long COVID) from routine laboratory tests, despite minor differences in some measures between infected and non-infected individuals.

13 Aug 2024

Long COVID's lasting toll: Economic losses, healthcare strain, and the urgent need for better global policies

Study reviews the impact of long COVID on individuals, health systems, and global economies, highlighting the need for a coordinated, patient-centered approach for future research and policy development.

12 Aug 2024

Mini intestines uncover mechanisms behind COVID-19-related diarrhea and potential treatments

Working with human stem cells that form a kind of "mini intestine-in-a-dish," Johns Hopkins Medicine scientists say they have found several molecular mechanisms for COVID-19-related diarrhea, suggesting potential ways to control it.

6 Aug 2024

Exploring long COVID: Insights into prevalence, pathophysiology, and treatment

In a new review paper, researchers from the Universities of Arizona, Oxford and Leeds analyzed dozens of previous studies into long COVID to examine the number and range of people affected, the underlying mechanisms of disease, the many symptoms that patients develop, and current and future treatments.

2 Aug 2024

COVID-19 Risk Calculator updated to assess a person's risk of developing long COVID

The University of Queensland-led and developed COVID-19 Risk Calculator has been updated to determine a person's risk of developing long COVID.

31 Jul 2024